Advertisement
Screener

Biomea Fusion, Inc. (BMEA) Material Contracts

Biomea Fusion, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-05-11: Form 10-Q; Exhibit 10.1; Description Change in Control and Severance Plan, dated March 25, 2025, by and between the Registrant and Michael J.M. Hitchcock.
  • 2026-03-24: Form 10-K; Exhibit 10.10; Description Separation Agreement and Release, dated May 1, 2025, by and between the Registrant and Thomas Butler.
  • 2025-11-04: Form 10-Q; Exhibit 10.1; Description Amendment to Employee Offer Letter Agreement by and between the Company and Michael J.M. Hitchcock.
  • 2025-05-05: Form 10-Q; Exhibit 10.1; Description Employment Offer Letter Agreement by and between the Company and Michael J.M. Hitchcock.
FiledFormExhibitDescription
2026-05-1110-Q10.1Change in Control and Severance Plan, dated March 25, 2025, by and between the Registrant and Michael J.M. Hitchcock
2026-03-2410-K10.10Separation Agreement and Release, dated May 1, 2025, by and between the Registrant and Thomas Butler
2025-11-0410-Q10.1Amendment to Employee Offer Letter Agreement by and between the Company and Michael J.M. Hitchcock
2025-05-0510-Q10.1Employment Offer Letter Agreement by and between the Company and Michael J.M. Hitchcock
2024-05-0210-Q10.1Offer Letter, dated July 24, 2023, by and between the Registrant and Juan Pablo Frias
2024-03-2810-K10.5.CUpdated Form Executive Change in Control and Severance Agreement adopted November 13, 2023
2022-09-098-K10.1Sublease Agreement between the Registrant and Box, Inc., dated September 7, 2022
2022-05-1610-Q10.1Form of Indemnification and Advancement Agreement for Directors and Officers
2021-08-1110-Q10.2Employment Offer Letter Agreement by and between the Registrant and Franco Valle
2021-08-1110-Q10.1Transition and Separation Agreement by and between the Registrant and Sunny Lee Ryan

Similar stocks

Stock NameCountryMarket CapPE Ratio
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Equillium, Inc. (EQ)United States$0.109B-11.27
GENELUX Corp (GNLX)United States$0.110B-3.83
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
ProMIS Neurosciences Inc. (PMN)$0.102B
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Anixa Biosciences Inc (ANIX)United States$0.096B